Market Value to Book Value Ratio: Cerus Corp (CERS)

Corporate emblem and logo of Cerus Corp (CERS)

Cerus Corporation (CERS) operates on counter-cyclical demand, as blood component purification remains critical regardless of market conditions. This chart of stock quotes at the value of 6.87 confirms the resilience of a model protected by strict patent law and its status as an industry benchmark. The company is currently focusing on the global implementation of its technologies and the completion of new product trials in Western clinics.

Cerus Inc (CERS) - Market-to-Book Ratio from 07/04/2022 to 10/29/2026

Summary analytical data breakdowns for Cerus Corp. (CERS)

- market value and analyst target forecast:
Price Chart Cerus Corporation|CERS - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value Cerus Corp|CERS - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Cerus|CERS - Total Stockholders' Equity|Market Capitalization to Book Value Ratio cerus.com|CERS - Total Business Assets
- debt and liquidity details:
Total Debt to Capital Cerus Corporation|CERS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Cerus Corp|CERS - Company Total Debt|Debts to Book Capitalization Cerus Corp|CERS - Company Long-Term Debts|Company Short-Term Debt Cerus|Quick Liquidity Indicator cerus.com
- earnings and valuation multiples indicators:
CERS - Final Profit
Basic company analysis:Cerus Corporation - CERS
Flagship merchandise of Cerus Corp.

This ratio measures the market premium over the net asset value, reflecting investor confidence in the company's capital stability and collateral base. Analyzing the historical relationship between market capitalization and book value reveals how the proprietary monopoly of Cerus Corporation (CERS) in blood safety and its significant pricing power maintain the company's valuation well above book value marks.

Competitor analysis

Intuitive Surgical (ISRG) - Market Value to Book Value Ratio|DHR - Market Capitalization to Book Value|Market Value to Book Value Ratio Becton Dickinson|Market Cap to Net Assets Ratio STERIS PLC (STE)|Market Capitalization to Book Value Ratio WST|BAX - Market-to-Book Ratio|Market Capitalization to Book Value Ratio MASI (Masimo Corporation)|STVN: Capitalization to Book Value Ratio|Teleflex - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Merit Medical Systems, Inc. MMSI|NVST: Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio ICU Medical Inc.|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio lemaitre.com|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio STAA (STAAR Surgical Co.)|niagenbioscience.com - Market Cap to Net Assets Ratio|Market Value to Book Value ZIMV|AngioDynamics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value teknova.com TKNO|Monogram Orthopedics (MGRM) - Market Value to Book Value Ratio|Capitalization to Book Value Ratio STSS|Market Value to Book Value Ratio InfuSystem|Utah Med (UTMD) - Market Capitalization to Book Value|Market Cap to Net Assets Ratio KRMD (KORU Medical Systems)|Market Cap to Book Value Multiple NYXH|Market Value to Book Value Ratio Microbot Medical MBOT|Market Value to Book Value PDEX|ZTEK: Market Cap to Net Assets Ratio|ELUT - Market Capitalization to Book Value Ratio|Milestone Scientific (MLSS) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio nexgel.com|RVP (Retractable Technologies Inc.) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Harvard Bioscience Inc. HBIO|Market Value to Book Value Ratio Femasys Corp (FEMY)|meihuamed.com - Capitalization to Book Value Ratio|Predictive Oncology Inc. - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple CJMB (Callan JMB Inc.)|ATRI - Market Value to Book Value Ratio|Market Capitalization to Book Value NeuroMetrix Inc NURO